Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunohistochemistry”

123 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 123 results

Not applicableActive Not RecruitingNCT06126159
What this trial is testing

MRI Functional Imaging Characteristics and Fat Quantification of CT-fat-free Renal Neoplasms: Relationships With Histological Classifications and Molecular Markers

Who this might be right for
Kidney Neoplasms
Chang Gung Memorial Hospital 44
Not applicableStudy completedNCT02042105
What this trial is testing

A Prospective Epidemiologic Study of ALK-Positive NSCLC in China

Who this might be right for
Non-small-cell Lung Cancer
Guangdong Association of Clinical Trials 3,649
Not applicableUnknownNCT03465930
What this trial is testing

Histologic Analysis of the Lymphatic Vessels Used for Supermicrosurgical Lymphatico-venous Anastomoses in Lymphedema

Who this might be right for
Lymphedema
Paolo Gennaro 200
Not applicableStudy completedNCT05644964
What this trial is testing

The Effect of Anemia in Adolescent and Advanced Age Pregnancies

Who this might be right for
Anemia PregnancyPlacenta Diseases
Celal Bayar University 80
Testing effectiveness (Phase 2)Looking for participantsNCT06330064
What this trial is testing

Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (IDeate-PanTumor02)

Who this might be right for
Recurrent or Metastatic Solid Tumors
Daiichi Sankyo 520
Not applicableActive Not RecruitingNCT07593573
What this trial is testing

The Exploration of MTAP Deletion in Osteosarcoma by Immunohistochemistry

Who this might be right for
OsteosarcomaMTAP DeletionImmunohistochemistry
Peking University People's Hospital 100
Testing effectiveness (Phase 2)Study completedNCT01229150
What this trial is testing

Randomized Phase II Study of AZD6244 (Mitogen-activated Protein Kinase Inhibitor) MEK-Inhibitor With Erlotinib in KRAS Wild Type Advanced Non-Small Cell Lung Cancer (NSCLC) and a Randomized Phase II Study of AZD6244 With Erlotinib in Mutant KRAS Adva...

Who this might be right for
Non Small Cell Lung Carcinoma
National Cancer Institute (NCI) 89
Not applicableStudy completedNCT06833840
What this trial is testing

Evaluation of the Expression and Prognostic Role of Tumor Stem Cell Marker SOX2 in Odontogenic Cysts and Tumors

Who this might be right for
Odontogenic CystsOdontogenic Tumors
Mansoura University 45
Testing effectiveness (Phase 2)Study completedNCT04031534
What this trial is testing

Study of Hypoxia Measured in F-Miso PET/Scan and MRI in Patients With Squamous Cells Carcinoma

Who this might be right for
Squamous Cell Carcinoma of the Oropharynx
Centre Henri Becquerel 16
Testing effectiveness (Phase 2)UnknownNCT04992715
What this trial is testing

PD-L1 Expression in Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
NanoMab Technology (UK) Limited 15
Not applicableStudy completedNCT02010047
What this trial is testing

Comparison of qPCR to IHC and FISH for Detection of ALK Fusion Mutations in FFPE Tissue From NSCLC Patients

Who this might be right for
Nonsmall Cell Lung Cancer
British Columbia Cancer Agency 166
Not applicableStudy completedNCT02978131
What this trial is testing

Histopathological Techniques and PCR on Tissues Included in Paraffin for the Diagnosis of Tuberculosis

Who this might be right for
TuberculosisDiagnostic Techniques and ProceduresSensitivity and Specificity+3 more
Lille Catholic University 20
Not applicableUnknownNCT01688232
What this trial is testing

The Immunoscore as a Prognostic Marker for Patients With a Colorectal Cancer

Who this might be right for
Colorectal CancerSurgical Resection of the Colorectal Tumor
Assistance Publique - Hôpitaux de Paris 459
Not applicableStudy completedNCT06496204
What this trial is testing

Swedish Physical Activity and Fitness Longitudinal Study

Who this might be right for
SarcopeniaPhysical FitnessMuscle Strength+2 more
Karolinska Institutet 429
Not applicableLooking for participantsNCT04300101
What this trial is testing

Mixed Molecular Clinical Index (MMCI) in Diffuse Large B-cell Lymphoma (DLBCL)

Who this might be right for
Diffuse Large B Cell Lymphoma
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 300
Not applicableActive Not RecruitingNCT06850506
What this trial is testing

Exploring the Expression Level of Cadherin 6 Protein (CDH6) in Primary Malignant Bone Tumor Specimens and Its Clinical Application in Prognosis Assessment

Who this might be right for
SarcomaSarcoma, BoneEwing Sarcoma+1 more
Peking University People's Hospital 70
Testing effectiveness (Phase 2)Study completedNCT00089635
What this trial is testing

Panitumumab (ABX-EGF) Monotherapy in Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal CancerMetastases
Amgen 203
Not applicableLooking for participantsNCT04030676
What this trial is testing

QuantiFERON-CMV Test in a Prediction for Colic Cytomegalovirus Reactivation During Ulcerative Colitis

Who this might be right for
Cytomegalovirus Infections
Centre Hospitalier Universitaire de Saint Etienne 196
Not applicableLooking for participantsNCT05557474
What this trial is testing

Development and Clinical Validation of Early-stage Lung Cancer Prognostic Kit

Who this might be right for
Lung CancerSurgeryRecurrence
Chung Shan Medical University 236
Early research (Phase 1)Ended earlyNCT04790903
What this trial is testing

A Study Evaluating the Safety, Efficacy and Pharmacokinetics of Venetoclax in Combination With Polatuzumab Vedotin Plus Rituximab (R) and Cyclophosphamide, Doxorubicin, Prednisone (CHP) in Participants With Untreated BCL-2 Immunohistochemistry (IHC)-Positive Diffuse Large B-Cell Lymphoma (DLBCL)

Who this might be right for
Lymphoma, Large B-Cell, Diffuse
Hoffmann-La Roche 50
Load More Results